Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel orally active antithrombotic agent from Fuji Yakuhin

March 27, 1997

Biological role of CD39 uncovered by Immunex and collaborators

March 26, 1997

Biogen licenses Hirulog

March 26, 1997

Cor Therapeutics receives nonapprovable letter for Integrilin NDA

March 26, 1997

CPMP approves lepirudin

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

Promising phase II data presented for Novastan in acute MI

March 21, 1997

Fujisawa presents selective, nonpeptide thrombin receptor inhibitor

March 21, 1997

Fujisawa selects orally active fibrinogen antagonist for clinical studies

March 20, 1997

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 24, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
BIO CEO 2025: Cognition CEO debates policy while advancing CT-1812
BioWorld
Cognition Therapeutics Inc. evolved from the work of a neuroscientist and a chemist working in the San Francisco Bay area, seeking out targets to block the...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...